Association between the macrophage inflammatory protein-l alpha gene polymorphism and Alzheimer's disease in the Chinese population

Neuroscience Letters

Volumn 433, Issue 2, 2008, Pages 125-128

  Li, Keshen ^a   Dai, Dawei ^b   Yao, Lifen ^b   Gu, Xuefeng ^c   Luan, Kuan ^a   Tian, Wenjing ^b   Zhao, Yashuang ^b   Wang, Binyou ^b  

^a HARBIN ENGINEERING UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c Seoul National University Hospital   (South Korea)

Author keywords

Alzheimer's disease; Association study; Macrophage inflammatory protein l alpha gene; Promoter polymorphism; Risk factor

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4; CHEMOKINE RECEPTOR; CYTOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MICROSATELLITE DNA;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CHINESE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHEMOKINE CCL3; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 39649090292     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.01.002     Document Type: Article

References (25)

1. Al-Sharif F.M., Makki R.F., Ollier W.E., and Hajeer A.H. A new microsatellite marker within the promoter region of the MIP-1A gene. Immunogenetics 49 (1999) 740-741
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. fourth ed. (1994), American Psychiatric Association, Washington, DC
3. Carta M.G., Serra P., Ghiani A., Manca E., Hardoy M.C., Del Giacco G.S., Diaz G., Carpiniello B., and Manconi P.E. Chemokines and pro-inflammatory cytokines in Down's syndrome: an early marker for Alzheimer-type dementia?. Psychother. Psychosom. 71 (2002) 233-236
4. Choi S.J., Oba T., Callander N.S., Jelinek D.F., and Roodman G.D. AML-1A and AML-1B regulation of MIP-1 alpha expression in multiple myeloma. Blood 101 (2003) 3778-3783
5. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., and Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 (1993) 921-923
6. Davatelis G., Tekamp-Olson P., Wolpe S.D., Hermsen K., Luedke C., Gallegos C., Coit D., Merryweather J., and Cerami A. Cloning and characterization of a cDNA for murine macrophage inflammatory protein(MIP), a novel monokine with inflammatory and chemokine properties. J. Exp. Med. 167 (1988) 1939-1944
7. Del Bo R., Comi G.P., Bresolin N., Castelli E., Conti E., Degiuli A., Ausenda C.D., and Scarlato G. The apolipoprotein E ε4 allele causes a faster decline of cognitive performances in Down's syndrome subjects. J. Neurol. Sci. 145 (1997) 87-91
8. Galimberti D., Schoonenboom N., Scarpini E., Scheltens P., and Dutch-Italian Alzheimer Research Group. Chemokines in serum and cerebrospinal fluid of Alzheimer's disease patients. Ann. Neurol. 53 (2003) 547-548
9. Jofre-Monseny L., Loboda A., Wagner A.E., Huebbe P., Boesch-Saadatmandi C., Jozkowicz A., Minihane A.M., Dulak J., and Rimbach G. Effects of apoE genotype on macrophage inflammation and heme oxygenase-1 expression. Biochem. Biophys. Res. Commun. 357 (2007) 319-324
10. Lue L.F., Rydel R., Brigham E.F., Yang L.B., Hampel H., Murphy Jr. G.M., Brachova L., Yan S.D., Walker D.G., Shen Y., and Rogers J. Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro. Glia 35 (2001) 72-79
11. Luster A.D. Chemokines-chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338 (1998) 436-445
12. Lynch J.R., Tang W., Wang H., Vitek M.P., Bennett E.R., Sullivan P.M., Warner D.S., and Laskowitz D.T. APOE genotype and an ApoE mimetic peptide modify the systemic and central nervous system inflammatory response. J. Biol. Chem. 278 (2003) 48529-48533
13. Man S.M., Ma Y.R., Shang D.S., Zhao W.D., Li B., Guo D.W., Fang W.G., Zhu L., and Chen Y.H. Peripheral T cells overexpress MIP-1α to enhance its transendothelial migration in Alzheimer's disease. Neurobiol. Aging 28 (2007) 485-496
14. McGeer E.G., and McGeer P.L. Inflammatory processes in Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 27 (2003) 741-749
15. McGeer P.L., and McGeer E.G. Polymorphisms in inflammatory genes and the risk of Alzheimer disease. Arch. Neurol. 58 (2001) 1790-1792
16. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
17. Mennicken F., Maki R., de Souza E.B., and Quirion R. Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning. Trends Pharmacol. Sci. 20 (1999) 73-78
18. Menten P., Wuyts A., and Van-Damme J. Macrophage inflammatory protein-1. Cytokine Growth Factor Rev. 13 (2002) 455-481
19. Owens T., Babcock A.A., Millward J.M., and Toft-Hansen H. Cytokine and chemokine inter-regulation in the inflamed or injured CNS. Brain Res. Brain Res. Rev. 48 (2005) 178-184
20. Sastre M., Klockgether T., and Heneka M.T. Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms. Int. J. Dev. Neurosci. 24 (2006) 167-176
21. Saunders A.M., Strittmatter W.J., Schmechel D., George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R., Alberts M.J., Hulette C., Crain B., Goldgaber D., and Roses A.D. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43 (1993) 1467-1472
22. Schall T.J., Bacon K., Camp R.D., Kaspari J.W., and Goeddel D.V. Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes. J. Exp. Med. 177 (1993) 1821-1826
23. Tripathy D., Thirumangalakudi L., and Grammas P. Expression of macrophage inflammatory protein 1-alpha is elevated in Alzheimer's vessels and is regulated by oxidative stress. J. Alzheimers Dis. 11 (2007) 447-455
24. Usdin K., and Grabczyk E. DNA repeat expansions and human disease. Cell. Mol. Life. Sci. 57 (2000) 914-931
25. Xia M.Q., and Hyman B.T. Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease. J. Neurovirol. 5 (1999) 32-41